CDTX Company Profile and Key Details

Q: Who are the executives of CDTX?

Dr. Taylor SandisonChief Medical OfficerDr. Kevin M. Forrest Ph.D.Founder and Chief Strategy OfficerMs. Carol WaldoSenior Vice President of Regulatory Affairs & Quality AssuranceMr. James M. BalkovecSenior Vice President of ResearchMs. Laura A. NavaltaSenior Vice President of Clinical OperationsDr. Les Tari Ph.D.Chief Scientific OfficerMr. Shane M. WardChief Operating Officer & Chief Legal OfficerDr. Preetam Shah M.B.A., Ph.D.Chief Financial Officer, Chief Bus. Officer & Principal Accounting OfficerDr. Leslie Tari Ph.D.Chief Scientific OfficerMs. Allison Lewis CCP, SPHRSenior Vice President of People & CultureDr. Jeffrey L. Stein Ph.D.Pres, Chief Executive Officer & Executive Director

NASDAQ : CDTX

Cidara Therapeutics

$221.38

At Close 4:00 PM

Not Actively Trading

64.21

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Cidara Therapeutics, Inc. (CDTX) stock remained unchanged at $221.38 a share on NASDAQ. The stock opened at $221.38, fluctuating between $221.38 to $221.38 during the session.

Stock Snapshot

221.38

Prev. Close

5.61B

Market Cap

221.38

Day Low

-19.76607142857143

P/E Ratio

-11.2

EPS (TTM)

-0.25

Cash Flow per Share

221.38

Open

25.36M

Number of Shares

221.38

Day High

74.08%

Free Float in %

-0.09

Book Value

2.69M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Jan 06, 2026	221.32	221.41	221.25	221.38	2.65M
Jan 05, 2026	221.11	221.42	221.07	221.32	1.33M
Jan 02, 2026	220.85	221.10	220.47	221.03	1.43M
Dec 31, 2025	220.75	220.96	220.75	220.89	509.82K
Dec 30, 2025	220.60	220.80	220.40	220.80	612.64K
Dec 29, 2025	220.80	221.00	220.41	220.41	1.27M
Dec 26, 2025	220.86	221.00	220.73	220.80	426.43K
Dec 24, 2025	220.66	221.00	220.66	220.86	145.74K
Dec 23, 2025	220.85	220.91	220.66	220.86	357.32K
Dec 22, 2025	220.78	221.00	220.73	220.85	528.18K
Dec 19, 2025	220.39	221.02	220.09	220.80	1.82M
Dec 17, 2025	220.11	220.31	219.91	220.31	559.43K
Dec 16, 2025	219.96	220.40	219.96	220.05	1.31M
Dec 15, 2025	220.45	220.45	219.79	220.10	1.27M
Dec 12, 2025	220.29	220.78	220.15	220.65	551.1K
Dec 11, 2025	219.86	220.34	219.81	220.19	745.18K
Dec 10, 2025	220.20	220.38	219.60	219.60	805.64K
Dec 09, 2025	220.06	220.31	219.76	220.29	824.56K
Dec 08, 2025	220.54	220.75	219.82	220.07	1.68M
Dec 05, 2025	220.21	220.90	220.02	220.36	637.05K

Contact Details

San Diego, CA 92121

United States

https://msd.platform-apps.io 858 752 6170

About Company

Cidara Therapeutics, Inc. is a biotechnology company specializing in the creation, advancement, and commercialization of extended-duration anti-infective drugs. Their mission targets the prevention and treatment of infectious diseases and certain cancers within the U.S. Their primary therapeutic candidate, rezafungin acetate, is an innovative echinocandin antifungal designed to combat and avert severe fungal infections such as candidemia and invasive candidiasis, conditions known for their high fatality rates. Additionally, Cidara utilizes its Cloudbreak platform to engineer conjugated therapies aimed at preventing and treating influenza as well as various other viral illnesses, including respiratory syncytial virus (RSV), human immunodeficiency virus (HIV), and SARS-CoV-2, the pathogen behind COVID-19. Originally incorporated in 2012 as K2 Therapeutics, Inc., the company adopted its current name, Cidara Therapeutics, Inc., in July 2014. Its operations are headquartered in San Diego, California.

Stock Peers

ARGX

-1.91-0.18%

argenx SE$1,053.46 REGN

-8.56-1.00%

Regeneron Pharmaceuticals, Inc.$843.47 VRTX

1.21+0.22%

Vertex Pharmaceuticals Incorporated$557.96 MDGL

-4.32-0.79%

Madrigal Pharmaceuticals, Inc.$542.61 UTHR

-1.78-0.36%

United Therapeutics Corporation$490.24 KRYS

2.24+0.61%

Krystal Biotech, Inc.$371.47 ONC

0.9+0.25%

BeOne Medicines AG$362.68 PRAX

-2.35-0.66%

Praxis Precision Medicines, Inc.$355.15 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 LGND

2.82+0.98%

Ligand Pharmaceuticals Incorporated$289.74

Frequently Asked Questions

What is the current Cidara Therapeutics, Inc. (CDTX) stock price?

Cidara Therapeutics, Inc. (NASDAQ: CDTX) stock price is $221.38 in the last trading session. During the trading session, CDTX stock reached the peak price of $221.38 while $221.38 was the lowest point it dropped to. The percentage change in CDTX stock occurred in the recent session was 0% while the dollar amount for the price change in CDTX stock was $0.00.

CDTX's industry and sector of operation?

The NASDAQ listed CDTX is part of Biotechnology industry that operates in the broader Healthcare sector. Cidara Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of CDTX?

Dr. Taylor Sandison
Chief Medical Officer
Dr. Kevin M. Forrest Ph.D.
Founder and Chief Strategy Officer
Ms. Carol Waldo
Senior Vice President of Regulatory Affairs & Quality Assurance
Mr. James M. Balkovec
Senior Vice President of Research
Ms. Laura A. Navalta
Senior Vice President of Clinical Operations
Dr. Les Tari Ph.D.
Chief Scientific Officer
Mr. Shane M. Ward
Chief Operating Officer & Chief Legal Officer
Dr. Preetam Shah M.B.A., Ph.D.
Chief Financial Officer, Chief Bus. Officer & Principal Accounting Officer
Dr. Leslie Tari Ph.D.
Chief Scientific Officer
Ms. Allison Lewis CCP, SPHR
Senior Vice President of People & Culture
Dr. Jeffrey L. Stein Ph.D.
Pres, Chief Executive Officer & Executive Director

How CDTX did perform over past 52-week?

CDTX's closing price is 1,354.53% higher than its 52-week low of $15.22 where as its distance from 52-week high of $221.42 is -0.02%.

How many employees does CDTX have?

Number of CDTX employees currently stands at 38.

Link for CDTX official website?

Official Website of CDTX is: https://msd.platform-apps.io

How do I contact CDTX?

CDTX could be contacted at phone 858 752 6170 and can also be accessed through its website. CDTX operates from 6310 Nancy Ridge Drive, San Diego, CA 92121, United States.

How many shares of CDTX are traded daily?

CDTX stock volume for the day was 2.69M shares. The average number of CDTX shares traded daily for last 3 months was 1.37M.

What is the market cap of CDTX currently?

The market value of CDTX currently stands at $5.61B with its latest stock price at $221.38 and 25.36M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	38
Beta	1.53
Sales or Revenue	$63.91M
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	38
Beta	1.53
Sales or Revenue	$63.91M
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

CDTX Company Profile and Key Details

Cidara Therapeutics

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Shareholding & Insider Activity

Earnings & Analyst Outlook

Financial & Profitability Overview

Quarterly Financial Highlights

Dividend & Fair Value

Company Overview

Key Takeaways

Price Forecast & Outlook

Valuation Metrics